Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Parkinson's disease"
DOI: 10.3233/jpd-171151
Abstract: BACKGROUND With recent advances in the search for disease-modifying therapies for Parkinson's disease (PD) the importance of identifying prodromal markers becomes greater. Non-manifesting LRRK2 mutation carriers (NMC) are at risk for developing PD, and provide…
read more here.
Keywords:
individual variability;
non manifesting;
manifesting lrrk2;
intra individual ... See more keywords